Literature DB >> 527598

Quantitative determination of praziquantel in body fluids by gas liquid chromatography.

H W Diekmann.   

Abstract

Praziquantel was determined in body fluids by gas liquid chromatography as follows: A known amount of an internal standard and 0.1 N sodium hydroxide solution was added to the sample to be analyzed. After extraction with methyl acetate/diisopropyl ether = 30/70, the organic extract was evaporated, the residue taken up in methylacetate and an aliquot injected for glc analysis. Separation was accomplished on a OV3 silicon oil phase, and for detection and quantitation, a thermoionic FID sensitized for nitrogen-containing compounds was used. The determination limit in serum is about 0.01 micrograms/ml. The relative standard deviation for serum concentrations of 0.1 micrograms/ml was found to be 4.5%.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 527598     DOI: 10.1007/BF03189416

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  2 in total

1.  A fluorometric method for the determination of praziquantel in blood-plasma and urine.

Authors:  J Pütter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

2.  Serum concentrations and renal excretion in humans after oral administration of praziquantel--results of three determination methods.

Authors:  K Patzschke; J Pütter; L A Wegner; F A Horster; H W Diekmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

  2 in total
  7 in total

1.  A fluorometric method for the determination of praziquantel in blood-plasma and urine.

Authors:  J Pütter
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

2.  Serum concentrations and renal excretion in humans after oral administration of praziquantel--results of three determination methods.

Authors:  K Patzschke; J Pütter; L A Wegner; F A Horster; H W Diekmann
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

Review 3.  Clinical pharmacokinetics of anthelmintic drugs.

Authors:  G Edwards; A M Breckenridge
Journal:  Clin Pharmacokinet       Date:  1988-08       Impact factor: 6.447

4.  Clinical pharmacology in normal volunteers of praziquantel, a new drug against schistosomes and cestodes. An example of a complex study covering both tolerance and pharmacokinetics.

Authors:  G Leopold; W Ungethüm; E Groll; H W Diekmann; H Nowak; D H Wegner
Journal:  Eur J Clin Pharmacol       Date:  1978-12-01       Impact factor: 2.953

5.  Quantitative studies on the occurrence of praziquantel in milk and plasma of lactating women.

Authors:  J Pütter; F Held
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1979       Impact factor: 2.441

6.  Absorption, distribution and excretion of the anthelmintic praziquantel (Droncit) in rainbow trout (Salmo gairdneri R.).

Authors:  H Björklund; G Bylund
Journal:  Parasitol Res       Date:  1987       Impact factor: 2.289

7.  Penetration of praziquantel into cerebrospinal fluid and cysticerci in human cysticercosis.

Authors:  D Overbosch; J C van de Nes; E Groll; H W Diekmann; A M Polderman; H Mattie
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.